BioNTech plans six new phase 3 oncology trials in 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. KLAR
3. KEYS
4. MRK
5. PANW
6. HD
7. UBER
8. SPY
9. PGR
10. NBIS

Go back to BioNTech plans six new phase 3 oncology trials in 2026
(NASDAQ: BNTX) Delayed: 113.12 +20.37 (21.96%)
Previous Close $92.75    52 Week High $ 
Open $109.29    52 Week Low $ 
Day High $116.00    P/E N/A 
Day Low $107.18    EPS $ 
Volume 8,777,366